Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Aptevo Therapeutics (APVO) Return on Assets (2016 - 2025)

Aptevo Therapeutics' Return on Assets history spans 10 years, with the latest figure at 0.95% for Q3 2025.

  • For Q3 2025, Return on Assets fell 97.0% year-over-year to 0.95%; the TTM value through Sep 2025 reached 0.95%, down 97.0%, while the annual FY2023 figure was 0.04%, 2.0% up from the prior year.
  • Return on Assets for Q3 2025 was 0.95% at Aptevo Therapeutics, up from 1.06% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.05% in Q3 2023 and bottomed at 1.06% in Q2 2025.
  • The 5-year median for Return on Assets is 0.02% (2021), against an average of 0.16%.
  • The largest annual shift saw Return on Assets increased 24bps in 2022 before it plummeted -108bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.02% in 2021, then soared by 95bps to 0.03% in 2022, then skyrocketed by 55bps to 0.05% in 2023, then crashed by -59bps to 0.02% in 2024, then tumbled by -4992bps to 0.95% in 2025.
  • Per Business Quant, the three most recent readings for APVO's Return on Assets are 0.95% (Q3 2025), 1.06% (Q2 2025), and 0.54% (Q1 2025).